1. Hypothalamitis: a diagnostic and therapeutic challenge

   • Antonio Bianchi
   • Marilda Mormando
   • Laura De Marinis

   OriginalPaper 03 May 2013 Pages: 197 - 202

   

2. Interplay between the intracellular energy sensor AMP-activated protein kinase (AMPK) and the estrogen receptor activities in regulating rat pituitary tumor cell (GH3) growth in vitro

   • Giovanni Tulipano
   • Lara Faggi
   • Andrea Giustina

   OriginalPaper 07 May 2013 Pages: 203 - 209

   

3. Pituitary carcinoma with endolymphatic sac metastasis

   • Irida Balili
   • Steven Sullivan
   • Ariel Barkan

   OriginalPaper 05 May 2013 Pages: 210 - 213

   

4. Subgaleal recurrence of craniopharyngioma of rapid growing pattern

   • César B. Gonçalves
   • Giovanna A. B. Lima
   • Giselle F. Taboada

   OriginalPaper 18 May 2013 Pages: 214 - 219

   

5. Familial acromegaly due to aryl hydrocarbon receptor-interacting protein (AIP) gene mutation in a Turkish cohort

   • Mutlu Niyazoglu
   • Muge Sayitoglu
   • Pinar Kadioglu

   OriginalPaper 07 June 2013 Pages: 220 - 226

   

6. Peptide receptor radionuclide therapy in a patient with disabling non-functioning pituitary adenoma

   • Jan Komor
   • Jean Claude Reubi
   • Emanuel R. Christ

   OriginalPaper 06 June 2013 Pages: 227 - 231

   

7. Increased carotid intima media thickness is associated with prolactin levels in subjects with untreated prolactinoma: a pilot study

   • Xiao-Bing Jiang
   • Cui-Ling Li
   • Hai-Jun Wang

   OriginalPaper 12 June 2013 Pages: 232 - 239

8. The effect of the ANKK1/DRD2 Taq1A polymorphism on weight changes of dopaminergic treatment in prolactinomas

   • A. P. Athanasoulia
   • C. Sievers
   • H. J. Schneider

   OriginalPaper 06 June 2013 Pages: 240 - 245

9. Male prolactinomas presenting with normal testosterone levels

   • Ilan Shimon
   • Carlos Benbassat

   OriginalPaper 12 June 2013 Pages: 246 - 250

   

10. Hypophysitis due to IgG4-related disease responding to treatment with azathioprine: an alternative to corticosteroid therapy

    • Carmela Caputo
    • Ali Bazargan
    • Warrick J. Inder

    OriginalPaper 23 June 2013 Pages: 251 - 256

    

11. MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients

    • Maria Luisa Torre
    • Giuseppina T. Russo
    • Salvatore Cannavo

    OriginalPaper 27 June 2013 Pages: 257 - 266

12. Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review

    • Sabrina Chiloiro
    • Antonio Bianchi
    • Laura De Marinis

    OriginalPaper 05 July 2013 Pages: 267 - 276

    

13. GH/IGF1 axis disturbances in the fibromyalgia syndrome: is there a rationale for GH treatment?

    • G. Cuatrecasas
    • C. Alegre
    • F. F. Casanueva

    ReviewPaper 09 April 2013 Pages: 277 - 283

    

14. Estrogen and selective estrogen receptor modulators (SERMs) for the treatment of acromegaly: a meta-analysis of published observational studies

    • Jennifer C. Stone
    • Justin Clark
    • Suhail A. R. Doi

    ReviewPaper 08 August 2013 Pages: 284 - 295

    

15. Evolution of ¹⁸FDG pituitary uptake after medical control of acromegaly

    • Jean-Christophe Maiza
    • Cedric Revel

    Letter 27 August 2013 Pages: 296 - 297